Dynamic circulating tumor cell profiling of biliary tract cancer patients receiving systemic therapy
Background Biliary tract cancers (BTCs) represent a heterogeneous and aggressive group of malignancies that arise from the biliary epithelial tree. The BTC metastatic state remains a very refractory state, and circulating tumor cells (CTC) can offer a window into the metastatic cascade. We applied a profiling method to understand CTC dynamics for patients with advanced stage BTCs receiving systemic therapy. Methods This was a prospective pilot study that included 15 patients with unresectable or metastatic BTCs receiving systemic therapy. CTCs were purified using a commercially available size-based method and enumerated using immunofluorescent staining for epithelial markers. CTC dynamics were benchmarked against conventional blood biomarkers and correlated with survival outcomes. Results We detected CTCs in every patient sample. CTC quantities did not decline during the early on-treatment time point and were correlated weakly with serum carbohydrate antigen 19–9 level and circulating tumor DNA median variant allele frequency. There was no significant correlation between baseline CTC quantities and progression-free or overall survival. Conclusions Our novel workflow, utilizing a commercially available CTC purification and enumeration process, enabled a sensitive method to quantitatively and serially monitor CTC abundance in a pilot study of patients with BTCs. Future studies will expand upon numbers of participants and the means to detect and characterize these rare metastatic precursor cells in patients with BTCs.
Authors
- Lauren Jung (ORCID: https://orcid.org/0009-0007-6216-0404)
- Joseph Wang Franses (ORCID: https://orcid.org/0000-0002-2517-4950)
- Aurelie Desgardin
- Marcos Santiago Figueroa (ORCID: https://orcid.org/0009-0009-2652-5503)
- Anjana A Pillai (ORCID: https://orcid.org/0000-0001-6783-2109)
- Chetan Nambiar (ORCID: https://orcid.org/0009-0003-1817-2628)
- Chih‐Yi Liao (ORCID: https://orcid.org/0000-0002-5114-3162)
- Namrata Anand (ORCID: https://orcid.org/0000-0002-7396-7058)
- Mingyang Li (ORCID: https://orcid.org/0000-0002-9789-2935)
- Sarah Martin
- Samantha Orozco
Institutions
- University of Chicago (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3389/fonc.2026.1959420
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00